Insider Trading & Ownership - Gupta Suneel

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Gupta Suneel
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-01-09
Sale
2024-01-11
8:00 pm
Protagonist Therapeutics IncPTGXGupta Suneel
Chief Development Officer
5,000$25$125,000232,567
(Direct)
View
2019-12-03
Purchase
2019-12-03
6:32 pm
Protagonist Therapeutics IncPTGXGupta Suneel
EVP Clinical Operations
30,000$5.13$153,90049,500
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-26
Tax Withholding
2024-02-28
8:00 pm
N/A
N/A
Protagonist Therapeutics IncPTGXGupta Suneel
Chief Development Officer
4,282$29.53183,285
(Direct)
View
2024-01-09
Exercise
2024-01-11
8:00 pm
N/A
N/A
Protagonist Therapeutics IncPTGXGupta Suneel
Chief Development Officer
5,000$7.38232,567
(Direct)
View
2024-01-09
Exercise
2024-01-11
8:00 pm
N/A
2029-01-14
Protagonist Therapeutics IncPTGXGupta Suneel
Chief Development Officer
5,000$0232,567
(Direct)
View
2024-01-02
Option Award
2024-01-04
8:15 pm
N/A
2034-01-02
Protagonist Therapeutics IncPTGXGupta Suneel
Chief Development Officer
90,750$0259,067
(Direct)
View
2023-10-19
Exercise
2023-10-23
4:31 pm
N/A
N/A
Protagonist Therapeutics IncPTGXGupta Suneel
Chief Development Officer
20,000$7.38218,317
(Direct)
View
2023-10-19
Exercise
2023-10-23
4:31 pm
N/A
2029-01-14
Protagonist Therapeutics IncPTGXGupta Suneel
Chief Development Officer
20,000$0218,317
(Direct)
View
2023-05-31
Tax Withholding
2023-06-02
7:51 pm
N/A
N/A
Protagonist Therapeutics IncPTGXGupta Suneel
Chief Development Officer
4,150$26.07148,037
(Direct)
View
2023-05-31
Option Award
2023-06-02
7:51 pm
N/A
N/A
Protagonist Therapeutics IncPTGXGupta Suneel
Chief Development Officer
12,000$0148,037
(Direct)
View
2023-01-16
Option Award
2023-01-18
7:56 pm
N/A
2033-01-15
Protagonist Therapeutics IncPTGXGupta Suneel
Chief Development Officer
144,375$0261,937
(Direct)
View
2022-04-26
Exercise
2022-04-26
9:42 pm
N/A
N/A
Protagonist Therapeutics IncPTGXGupta Suneel
Chief Development Officer
40,000$7.38187,561
(Direct)
View
2022-04-26
Exercise
2022-04-26
9:42 pm
N/A
2029-01-14
Protagonist Therapeutics IncPTGXGupta Suneel
Chief Development Officer
40,000$0187,561
(Direct)
View
2022-02-28
Tax Withholding
2022-03-02
8:40 pm
N/A
N/A
Protagonist Therapeutics IncPTGXGupta Suneel
Chief Development Officer
649$24.2877,007
(Direct)
View
2022-02-15
Option Award
2022-02-17
7:24 pm
N/A
2032-02-14
Protagonist Therapeutics IncPTGXGupta Suneel
Chief Development Officer
87,500$0152,656
(Direct)
View
2021-02-26
Option Award
2021-02-26
6:27 pm
N/A
2031-02-25
Protagonist Therapeutics IncPTGXGupta Suneel
Chief Development Officer
92,000$0143,987
(Direct)
View
2020-02-28
Option Award
2020-02-28
5:44 pm
N/A
2030-02-27
Protagonist Therapeutics IncPTGXGupta Suneel
Chief Development Officer
85,000$085,000
(Direct)
View